CONNECT WITH US
Web3 & Blockchain

Web3 & Blockchain

NBIS Price Prediction: Citi trims target as NBIS tests nearby support

Blockchain.News logo

Published on

Add as a preferred source on Google
NBIS Price Prediction: Citi trims target as NBIS tests nearby support

Nebius Group Tokenized Stock is trading at $129.72, just above its pivot at $129.89 and below its 7-day, 20-day and 50-day moving averages. Citi lowered its price target to $265 from $324 and kept ...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

Nebius Group Tokenized Stock (NBIS) was last quoted at $129.72, up 0.49% over 24 hours, but the broader trend remains weak. The price is below the 7-day SMA at $138.89, the 20-day SMA at $154.88, the 50-day SMA at $195.49, the 12-day EMA at $144.99 and the 26-day EMA at $162.36, which leaves the market below the short- and intermediate-term averages used in this analysis.

The clearest reported fundamental update came from Tyler Radke at Citigroup, who lowered Nebius Group’s price target to $265 from $324 on November 4, 2026, while keeping a Buy rating ahead of the company’s third-quarter earnings report. That target is an analyst valuation, not a short-term trading forecast, but it does show that Citi still sees upside relative to the current quoted price.

The current price is sitting very close to the pivot point at $129.89, which makes this area the first level that matters. Immediate support is $122.65, with stronger support at $115.57. On the upside, immediate resistance is $136.97 and stronger resistance is $144.21.

Momentum is still soft rather than broken outright. 0000 show that downside momentum has cooled but has not yet turned constructive. 17 for %D also keep the setup near the lower end of the recent range without confirming a reversal.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.